Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, chlamydia trachomatis, and human papilloma virus

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Malogajski, Jelena ^a   Brankovic, Ivan ^a   Verweij, Stephan P ^b   Ambrosino, Elena ^a   Van Agtmael, Michiel A ^b   Brand, Angela ^a   Ouburg, Sander ^b   Morré, Servaas A ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BRCA1 PROTEIN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENFUVIRTIDE; GAMMA INTERFERON; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; MARAVIROC; MICRORNA; PROTEIN P53; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; VICRIVIROC;

ALLELE; CD4+ T LYMPHOCYTE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONDYLOMA ACUMINATUM; CPG ISLAND; DRUG RECEPTOR BINDING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; PROTEIN EXPRESSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; VERTICAL TRANSMISSION; VIRUS ENTRY; WART VIRUS; FEMALE; GENETICS; GENOMICS; HEALTH CARE DELIVERY; HOST PATHOGEN INTERACTION; MICROBIOLOGY; PAPILLOMA VIRUS; PROCEDURES; TRANSLATIONAL RESEARCH; UTERINE CERVIX TUMOR; VIROLOGY; ARTICLE; METHODOLOGY;

CHLAMYDIA TRACHOMATIS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS;

CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DELIVERY OF HEALTH CARE; FEMALE; GENOMICS; HIV; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; PAPILLOMAVIRIDAE; TRANSLATIONAL MEDICAL RESEARCH; UTERINE CERVICAL NEOPLASMS;

EID: 84878714773     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/892106     Document Type: Review

References (74)

1. Frodsham A. J., Hill A. V. S., Genetics of infectious diseases. Human Molecular Genetics 2004 13 2 R187 R194 2-s2.0-5444251622 10.1093/hmg/ddh225 (Pubitemid 39359902)
2. Burke W., Khoury M. J., Stewart A., Zimmern R. L., The path from genome-based research to population health: development of an international public health genomics network. Genetics in Medicine 2006 8 7 451 458 2-s2.0-33747874300 10.1097/01.gim.0000228213.72256.8c (Pubitemid 44289008)
3. Hill A. V. S., Aspects of genetic susceptibility to human infectious diseases. Annual Review of Genetics 2006 40 469 486 2-s2.0-33845631591 10.1146/annurev.genet.40.110405.090546 (Pubitemid 44956793)
4. Hill A. V. S., Immunogenetics and genomics. Lancet 2001 357 9273 2037 2041 2-s2.0-0035938951 10.1016/S0140-6736(00)05117-5 (Pubitemid 32592396)
5. Rowell J. L., Dowling N. F., Yu W., Yesupriya A., Zhang L., Gwinn M., Trends in population-based studies of human genetics in infectious diseases. PLoS One 2012 7 2 10.1371/journal.pone.0025431 e25431
6. Khoury M. J., Gwinn M., Clyne M., Yu W., Genetic epidemiology with a capital E, ten years after. Genetic Epidemiology 2011 35 8 845 852 10.1002/gepi.20634
7. Lal J. A., Schulte In den Baumen T., Morre S. A., Brand A., Public health and valorization of genome-based technologies: a new model. Journal of Translational Medicine 2011 9 article 207 10.1186/1479-5876-9-207
8. Yu W., Gwinn M., Clyne M., Yesupriya A., Khoury M. J., A navigator for human genome epidemiology. Nature Genetics 2008 40 2 124 125 2-s2.0-38649091333 10.1038/ng0208-124 (Pubitemid 351171407)
9. UNAIDS, UNAIDS report on the global AIDS epidemic 2010. Global Report 2010
10. CDC, Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. Morbidity and Mortality Weekly Report 2001 50 RR-13 1 35
11. An P., Winkler C. A., Host genes associated with HIV/AIDS: advances in gene discovery. Trends in Genetics 2010 26 3 119 131 2-s2.0-76749167054 10.1016/j.tig.2010.01.002
12. Tang J., Kaslow R. A., The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy. AIDS 2003 17 supplement 4 S51 S60
13. He W., Castiblanco J., Walter E. A., Okulicz J. F., Ahuja S. K., Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes. Current Opinion in HIV and AIDS 2010 5 6 545 559 10.1097/COH.0b013e32833f2087
14. O'Brien S. J., Nelson G. W., Winkler C. A., Smith M. W., Polygenic and multifactorial disease gene association in man: lessons from AIDS. Annual Review of Genetics 2000 34 563 591 (Pubitemid 32065933)
15. Kaslow R. A., Dorak T., Tang J., Influence of host genetic variation on susceptibility to HIV type 1 infection. Journal of Infectious Diseases 2005 191 supplement 1 S68 S77 2-s2.0-12444282714 10.1086/425269 (Pubitemid 40144231)
16. Singh K. K., Spector S. A., Host genetic determinants of human immunodeficiency virus infection and disease progression in children. Pediatric Research 2009 65 5, part 2 55R 63R 2-s2.0-68049118309 10.1203/PDR. 0b013e31819dca03
17. Smith M. W., Dean M., Carrington M., Winkler C., Huttley G. A., Lomb D. A., Goedert J. J., 'Brien TR O., Jacobson L. P., Kaslow R., Buchbinder S., Vittinghoff E., Vlahov D., Hoots K., Hilgartner M. W., O'Brien S. J., Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997 277 5328 959 965
18. Hütter G., Ganepola S., The ccr5-delta32 polymorphism as a model to study host adaptation against infectious diseases and to develop new treatment strategies. Experimental Biology and Medicine 2011 236 8 938 943 2-s2.0-79961204638 10.1258/ebm.2011.010241
19. McKinnell J. A., Saag M. S., Novel drug classes: entry inhibitors [enfuvirtide, chemokine (C-C motif) receptor 5 antagonists]. Current Opinion in HIV and AIDS 2009 4 6 513 517 2-s2.0-70350165412 10.1097/COH.0b013e328331d3d0
20. Singh I. P., Chauthe S. K., Small molecule HIV entry inhibitors. Part I: chemokine receptor antagonists: 2004-2010. Expert Opinion on Therapeutic Patents 2011 21 2 227 269 2-s2.0-79952048310 10.1517/13543776.2011.542412
21. Gilliam B. L., Riedel D. J., Redfield R. R., Clinical use of CCR5 inhibitors in HIV and beyond. Journal of Translational Medicine 2011 9 supplement 1, article S9 2-s2.0-79251519312 10.1186/1479-5876-9-S1-S9
22. Carrington M., O'Brien S. J., The Influence of HLA Genotype on AIDS. Annual Review of Medicine 2003 54 535 551 2-s2.0-0038581912 10.1146/annurev.med. 54.101601.152346 (Pubitemid 37386411)
23. den Uyl D., van der Horst-Bruinsma I. E., van Agtmael M., Progression of HIV to AIDS: a protective role for HLA-B27? AIDS Reviews 2004 6 2 89 96 2-s2.0-4344577957
24. O'Brien S. J., Nelson G. W., Human genes that limit AIDS. Nature Genetics 2004 36 6 565 574 2-s2.0-2642563503 10.1038/ng1369 (Pubitemid 38715980)
25. Chapman S. J., Hill A. V., Human genetic susceptibility to infectious disease. Nature Reviews Genetics 2012 13 3 175 188
26. Mallal S., Nolan D., Witt C., Masel G., Martin A. M., Moore C., Sayer D., Castley A., Mamotte C., Maxwell D., James I., Christiansen F. T., Association between presence of HLA-B·5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002 359 9308 727 732 2-s2.0-0037006623 10.1016/S0140-6736(02)07873-X (Pubitemid 34215071)
27. Bailey R. L., Natividad-Sancho A., Fowler A., Peeling R. W. W., Mabey D. C. W., Whittle H. C., Jepson A. P., Host genetic contribution to the cellular immune response to Chlamydia trachomatis: heritability estimate from a Gambian twin study. Drugs of Today 2009 45 45 50 2-s2.0-60049091592
28. WHO, Sexually Transmitted Diseases. Disease Burden 2012
29. Starnbach M. N., Roan N. R., Conquering sexually transmitted diseases. Nature Reviews Immunology 2008 8 4 313 317 2-s2.0-41149163239 10.1038/nri2272 (Pubitemid 351432800)
30. Land J. A., Van Bergen J. E. A. M., Morré S. A., Postma M. J., Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Human Reproduction Update 2009 16 2 189 204 2-s2.0-71249110000 10.1093/humupd/dmp035 dmp035
31. den Hartog J. E., Ouburg S., Land J. A., Lyons J. M., Ito J. I., Peña A. S., Morré S. A., Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis- associated tubal pathology in subfertile women? BMC Infectious Diseases 2006 6 article 122 2-s2.0-33748208829 10.1186/1471-2334-6-122 (Pubitemid 44314343)
32. den Hartog J. E., Morré S. A., Land J. A., Chlamydia trachomatis-associated tubal factor subfertility: immunogenetic aspects and serological screening. Human Reproduction Update 2006 12 6 719 730 2-s2.0-33750223872 10.1093/humupd/dml030 (Pubitemid 44605510)
33. Darville T., O'Neill J. M., Andrews C. W., Nagarajan U. M., Stahl L., Ojcius D. M., Toll-like receptor-2, but not toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. Journal of Immunology 2003 171 11 6187 6197 2-s2.0-0344585387 (Pubitemid 37467242)
34. Den Hartog J. E., Lyons J. M., Ouburg S., Fennema J. S. A., De Vries H. J. C., Bruggeman C. A., Ito J. I., Peña A. S., Land J. A., Morré S. A., TLR4 in chlamydia trachomatis infections: knockout mice, STD patients and women with tubal factor subfertility. Drugs of Today B 2009 45 75 82 2-s2.0-71249112746
35. Kawai T., Akira S., TLR signaling. Cell Death and Differentiation 2006 13 5 816 825 2-s2.0-33645960706 10.1038/sj.cdd.4401850
36. Laisk T., Peters M., Saare M., Haller-Kikkatalo K., Karro H., Salumets A., Association of CCR5, TLR2, TLR4 and MBL genetic variations with genital tract infections and tubal factor infertility. Journal of Reproductive Immunology 2010 87 1-2 74 81 2-s2.0-78449272661 10.1016/j.jri.2010.06.001
37. Karimi O., Ouburg S., De Vries H. J. C., Peña A. S., Pleijster J., Land J. A., Morré S. A., TLR2 haplotypes in the susceptibility to and severity of Chlamydia trachomatis infections in Dutch women. Drugs of Today B 2009 45 67 74 2-s2.0-71249121452
38. Ouburg S., Lyons J. M., Land J. A., Den Hartog J. E., Fennema J. S. A., De Vries H. J. C., Bruggeman C. A., Ito J. I., Peña A. S., Lundberg P. S. J., Morré S. A., TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection. Drugs of Today B 2009 45 83 93 2-s2.0-71249133671
39. Cohen C. R., Sinei S. S., Bukusi E. A., Bwayo J. J., Holmes K. K., Brunham R. C., Human leukocyte antigen class II DQ alleles associated with Chlamydia trachomatis tubal infertility. Obstetrics & Gynecology 2000 95 1 72 77 (Pubitemid 30001633)
40. Cohen C. R., Gichui J., Rukaria R., Sinei S. S., Gaur L. K., Brunham R. C., Immunogenetic correlates for Chlamydia trachomatis-associated tubal infertility. Obstetrics & Gynecology 2003 101 3 438 444 (Pubitemid 36288481)
41. Kinnunen A. H., Surcel H. M., Lehtinen M., Karhukorpi J., Tiitinen A., Halttunen M., Bloigu A., Morrison R. P., Karttunen R., Paavonen J., HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Human Reproduction 2002 17 8 2073 2078 2-s2.0-0035988513
42. Morré S. A., Karimi O., Ouburg S., Chlamydia trachomatis: identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics. FEMS Immunology and Medical Microbiology 2009 55 2 140 153 2-s2.0-60049096115 10.1111/j.1574-695X.2009.00536.x
43. Lal J. A., Malogajski J., Verweij S. P., de Boer P., Ambrosino E., Brand A., Ouburg S., Morré S. A., Chlamydia trachomatis infections and subfertility: opportunities to translate host pathogen genomic data into public health. Public Health Genomics 2013 16 1-2 50 61
44. Evers J. L. H., Female subfertility. Lancet 2002 360 9327 151 159 2-s2.0-0037072099 10.1016/S0140-6736(02)09417-5 (Pubitemid 34786208)
45. Broeze K. A., Opmeer B. C., van der Veen F., Bossuyt P. M., Bhattacharya S., Mol B. W. J., Individual patient data meta-analysis: a promising approach for evidence synthesis in reproductive medicine. Human Reproduction Update 2010 16 6 561 567 2-s2.0-78649366692 10.1093/humupd/dmq043
46. Broeze K. A., Opmeer B. C., Coppus S. F. P. J., Van Geloven N., Alves M. F. C., Ånestad G., Bhattacharya S., Allan J., Guerra-Infante M. F., Den Hartog J. E., Land J. A., Idahl A., Van der Linden P. J. Q., Mouton J. W., Ng E. H. Y., Van der Steeg J. W., Steures P., Svenstrup H. F., Tiitinen A., Toye B., Van der Veen F., Mol B. W., Chlamydia antibody testing and diagnosing tubal pathology in subfertile women: an individual patient data meta-analysis. Human Reproduction Update 2011 17 3 301 310 2-s2.0-79954473219 10.1093/humupd/dmq060
47. Wills G. S., Horner P. J., Reynolds R., Johnson A. M., Muir D. A., Brown D. W., Winston A., Broadbent A. J., Parker D., McClure M. O., Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection. Clinical and Vaccine Immunology 2009 16 6 835 843 2-s2.0-67249087252 10.1128/CVI.00021-09
48. Roman E., Simpson J., Ansell P., Kinsey S., Mitchell C. D., McKinney P. A., Birch J. M., Greaves M., Eden T., Childhood acute lymphoblastic leukemia and infections in the first year of life: a report from the United Kingdom Childhood Cancer Study. American Journal of Epidemiology 2007 165 5 496 504 2-s2.0-33847363217 10.1093/aje/kwk039 (Pubitemid 46340551)
49. An H. J., Kim K. R., Kim I. S., Kim D. W., Park M. H., Park I. A., Suh K. S., Seo E. J., Sung S. H., Sohn J. H., Yoon H. K., Chang E. D., Cho H. I., Han J. Y., Hong S. R., Ahn G. H., Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population-based study. Modern Pathology 2005 18 4 528 534 2-s2.0-20144387121 10.1038/modpathol.3800316 (Pubitemid 40478116)
50. Lehoux M., D'Abramo C. M., Archambault J., Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics 2009 12 5-6 268 280 2-s2.0-69249128732 10.1159/000214918
51. Baseman J. G., Koutsky L. A., The epidemiology of human papillomavirus infections. Journal of Clinical Virology 2005 32 supplement 1 S16 S24 2-s2.0-14744293594 10.1016/j.jcv.2004.12.008 (Pubitemid 40332585)
52. Pao C. C., Tsai P. L., Chang Y. L., Hsieh T. T., Jin J. Y., Non-sexual papillomavirus transmission routes. Lancet 1992 339 8807 1479 1480 2-s2.0-0026652774
53. Burchell A. N., Winer R. L., de Sanjose S., Franco E. L., Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006 24 supplement 3 52 61
54. Tay S. K., Genital oncogenic human papillomavirus infection: a short review on the mode of transmission. Annals, Academy of Medicine, Singapore 1995 24 4 598 601
55. Schiffman M., Castle P. E., Human papillomavirus: epidemiology and public health. Archives of Pathology and Laboratory Medicine 2003 127 8 930 934 2-s2.0-0041673351 (Pubitemid 36994850)
56. Syrjänen K., Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix. European Journal of Gynaecological Oncology 2007 28 5 337 351 2-s2.0-35148901152 (Pubitemid 47535544)
57. Harper D. M., Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health. Public Health Genomics 2009 12 5-6 319 330 2-s2.0-69249128375 10.1159/000214922
58. Hildesheim A., Wang S. S., Host and viral genetics and risk of cervical cancer: a review. Virus Research 2002 89 2 229 240 2-s2.0-0036849735 10.1016/S0168-1702(02)00191-0 (Pubitemid 35351541)
59. Cuzick J., Terry G., Ho L., Monaghan J., Lopes A., Clarkson P., Duncan I., Association between high-risk HPV types, HLA DRB1· and DQB1· alleles and cervical cancer in British women. British Journal of Cancer 2000 82 7 1348 1352 2-s2.0-0034015236 (Pubitemid 30145357)
60. Cervantes J., Lema C., Hurtado L. V., Andrade R., Gomez L. H., Torrico L., Zegarra L., Quiroga G., Asturizaga D., Dulon A., Prada R., Panoso W., Yashiki S., Fujiyoshi T., Sonoda S., HLA-DRB1·1602 allele is positively associated with HPV cervical infection in Bolivian Andean women. Human Immunology 2003 64 9 890 895 2-s2.0-0042835382 10.1016/S0198-8859(03)00163-0 (Pubitemid 37093461)
61. Chen X., Jiang J., Shen H., Hu Z., Genetic susceptibility of cervical cancer. Journal of Biomedical Research 2011 25 3 155 164 2-s2.0-79959398453 10.1016/S1674-8301(11)60020-1
62. Arnheim L., Dillner J., Sanjeevi C. B., A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia. Tissue Antigens 2005 65 3 252 259 2-s2.0-14844310289 10.1111/j.1399-0039.2005. 00359.x (Pubitemid 40342431)
63. Yang N., Eijsink J. J. H., Lendvai A., Volders H. H., Klip H., Buikema H. J., Van Hemel B. M., Schuuring E., Van Der Zee A. G. J., Wisman G. B. A., Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiology Biomarkers and Prevention 2009 18 11 3000 3007 2-s2.0-72749123551 10.1158/1055-9965.EPI-09-0405
64. Esteller M., Herman J. G., Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. Journal of Pathology 2002 196 1 1 7 2-s2.0-0036145156 10.1002/path.1024 (Pubitemid 34071572)
65. Henken F. E., Wilting S. M., Overmeer R. M., Van Rietschoten J. G. I., Nygren A. O. H., Errami A., Schouten J. P., Meijer C. J. L. M., Snijders P. J. F., Steenbergen R. D. M., Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. British Journal of Cancer 2007 97 10 1457 1464 2-s2.0-36148988789 10.1038/sj.bjc.6604055 (Pubitemid 350114795)
66. Nanda K., McCrory D. C., Myers E. R., Bastian L. A., Hasselblad V., Hickey J. D., Matchar D. B., Accuracy of the papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Annals of Internal Medicine 2000 132 10 810 819 2-s2.0-0034673956 (Pubitemid 30317797)
67. NIH, Cervical Cancer Screening. 2012
68. Ronco G., Giorgi-Rossi P., Carozzi F., Confortini M., Palma P. D., Del Mistro A., Ghiringhello B., Girlando S., Gillio-Tos A., De Marco L., Naldoni C., Pierotti P., Rizzolo R., Schincaglia P., Zorzi M., Zappa M., Segnan N., Cuzick J., Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. The Lancet Oncology 2010 11 3 249 257 2-s2.0-77649187281 10.1016/S1470-2045(09)70360-2
69. Overmeer R. M., Louwers J. A., Meijer C. J., van Kemenade F. J., Hesselink A. T., Daalmeijer N. F., Wilting S. M., Heideman D. A., Verheijen R. H., Zaal A., van Baal W. M., Berkhof J., Snijders P. J., Steenbergen R. D., Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women. International Journal of Cancer 2011 129 9 2218 2225 10.1002/ijc.25890
70. Wilting S. M., van Boerdonk R. A. A., Henken F. E., Meijer C. J. L. M., Diosdado B., Meijer G. A., le Sage C., Agami R., Snijders P. J. F., Steenbergen R. D. M., Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. Molecular Cancer 2010 9 article 167 2-s2.0-77953853387 10.1186/1476-4598-9-167
71. Solomon D., Chapter 14: role of triage testing in cervical cancer screening. Journal of the National Cancer Institute Monographs 2003 31 97 101 2-s2.0-0142125384
72. Teutsch S. M., Bradley L. A., Palomaki G. E., Haddow J. E., Piper M., Calonge N., Dotson W. D., Douglas M. P., Berg A. O., The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP working group. Genetics in Medicine 2009 11 1 3 14 2-s2.0-59849108152 10.1097/GIM.0b013e318184137c
73. Burke W., Atkins D., Gwinn M., Guttmacher A., Haddow J., Lau J., Palomaki G., Press N., Richards C. S., Wideroff L., Wiesner G. L., Khoury M., Genetic test evaluation: information needs of clinicians, policy makers, and the public. American Journal of Epidemiology 2002 156 4 311 318 2-s2.0-0037103382 10.1093/aje/kwf055 (Pubitemid 34857998)
74. Little J., Bradley L., Bray M. S., Clyne M., Dorman J., Ellsworth D. L., Hanson J., Khoury M., Lau J., O'Brien T. R., Rothman N., Stroup D., Taioli E., Thomas D., Vainio H., Wacholder S., Weinberg C., Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. American Journal of Epidemiology 2002 156 4 300 310 2-s2.0-0037103172 10.1093/aje/kwf054 (Pubitemid 34857997)